|
1
|
Bandyopadhyay A, Wang L, Agyin J, Tang Y,
Lin S, Yeh IT, De K and Sun LZ: Doxorubicin in combination with a
small TGFβ inhibitor: A potential novel therapy for metastatic
breast cancer in mouse models. PLoS One. 5:e103652010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–17.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ben-Eliyahu S: The promotion of tumor
metastasis by surgery and stress: Immunological basis and
implications for psychoneuroimmunology. Brain Behav Immun.
17:S27–S36. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldfarb Y and Ben-Eliyahu S: Surgery as a
risk factor for breast cancer recurrence and metastasis: Mediating
mechanisms and clinical prophylactic approaches. Breast Dis.
26:99–114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Biswas S, Guix M, Rinehart C, Dugger TC,
Chytil A, Moses HL, Freeman ML and Arteaga CL: Inhibition of
TGF-beta with neutralizing antibodies prevents radiation-induced
acceleration of metastatic cancer progression. J Clin Invest.
117:1305–1313. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kaliski A, Maggiorella L, Cengel KA, Mathe
D, Rouffiac V, Opolon P, Lassau N, Bourhis J and Deutsch E:
Angiogenesis and tumor growth inhibition by a matrix
metalloproteinase inhibitor targeting radiation-induced invasion.
Mol Cancer Ther. 4:1717–1728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhai GG, Malhotra R, Delaney M, Latham D,
Nestler U, Zhang M, Mukherjee N, Song Q, Robe P and Chakravarti A:
Radiation enhances the invasive potential of primary glioblastoma
cells via activation of the Rho signaling pathway. J Neurooncol.
76:227–237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
den Besten G, van Eunen K, Groen AK,
Venema K, Reijngoud DJ and Bakker BM: The role of short-chain fatty
acids in the interplay between diet, gut microbiota, and host
energy metabolism. J Lipid Res. 54:2325–2340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Louis M, Rosato RR, Brault L, Osbild S,
Battaglia E, Yang XH, Grant S and Bagrel D: The histone deacetylase
inhibitor sodium butyrate induces breast cancer cell apoptosis
through diverse cytotoxic actions including glutathione depletion
and oxidative stress. Int J Oncol. 25:1701–1711. 2004.PubMed/NCBI
|
|
10
|
Louis P, Hold GL and Flint HJ: The gut
microbiota, bacterial metabolites and colorectal cancer. Nat Rev
Microbiol. 12:661–672. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lane AA and Chabner BA: Histone
deacetylase inhibitors in cancer therapy. J Clin Oncol.
27:5459–5468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berni Canani R, Di Costanzo M and Leone L:
The epigenetic effects of butyrate: Potential therapeutic
implications for clinical practice. Clin Epigenetics. 4:42012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen HC, Jeng YM, Yuan RH, Hsu HC and Chen
YL: SIRT1 promotes tumorigenesis and resistance to chemotherapy in
hepatocellular carcinoma and its expression predicts poor
prognosis. Ann Surg Oncol. 19:2011–2019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang T, Rong N, Chen J, Zou C, Jing H,
Zhu X and Zhang W: SIRT1 expression is associated with the
chemotherapy response and prognosis of patients with advanced
NSCLC. PLoS One. 8:e791622013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osama A, Sabry D, Hassany SM, Abdelmoneim
SS and Sabry A: SIRT-1expression is associated with expression of
NANOG in patients with colorectal adenocarcinoma. Cancer Biomark.
17:155–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao B, He X, Wang W and Shi M: SIRT1
Influences the sensitivity of A549 non-small cell lung cancer cell
line to cisplatin via modulating the Noxa expression. Zhongguo Fei
Ai Za Zhi. 19:57–63. 2016.(In Chinese). PubMed/NCBI
|
|
17
|
Pant K, Yadav AK, Gupta P, Islam R, Saraya
A and Venugopal SK: Butyrate induces ROS-mediated apoptosis by
modulating miR-22/SIRT-1 pathway in hepatic cancer cells. Redox
Biol. 12:340–349. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guertin DA and Sabatini DM: Defining the
role of mTOR in cancer. Cancer Cell. 12:9–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma XM and Blenis J: Molecular mechanisms
of mTOR-mediated translational control. Nat Rev Mol Cell Biol.
10:307–318. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong S, Zhao B, Lombard DB, Fingar DC and
Inoki K: Cross-talk between sirtuin and mammalian target of
rapamycin complex 1 (mTORC1) signaling in the regulation of S6
kinase 1 (S6K1) phosphorylation. J Biol Chem. 289:13132–13141.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oberdoerffer P, Michan S, McVay M,
Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner
A, Loerch P, et al: SIRT1 redistribution on chromatin promotes
genomic stability but alters gene expression during aging. Cell.
135:907–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bolden JE, Peart MJ and Johnstone RW:
Anticancer activities of histone deacetylase inhibitors. Nat Rev
Drug Discov. 5:769–784. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma X, Ezzeldin HH and Diasio RB: Histone
deacetylase inhibitors: Current status and overview of recent
clinical trials. Drugs. 69:1911–1934. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tailor D, Hahm ER, Kale RK, Singh SV and
Singh RP: Sodium butyrate induces DRP1-mediated mitochondrial
fusion and apoptosis in human colorectal cancer cells.
Mitochondrion. 16:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Medina V, Edmonds B, Young GP, James R,
Appleton S and Zalewski PD: Induction of caspase-3 protease
activity and apoptosis by butyrate and trichostatin A (inhibitors
of histone deacetylase): Dependence on protein synthesis and
synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer
Res. 57:3697–3707. 1997.PubMed/NCBI
|
|
27
|
Tang Y, Chen Y, Jiang H and Nie D:
Short-chain fatty acids induced autophagy serves as an adaptive
strategy for retarding mitochondria-mediated apoptotic cell death.
Cell Death Differ. 18:602–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiao D, Vogel V and Singh SV: Benzyl
isothiocyanate-induced apoptosis in human breast cancer cells is
initiated by reactive oxygen species and regulated by Bax and Bak.
Mol Cancer Ther. 5:2931–2945. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER,
Dhir R and Singh SV: Diallyl trisulfide suppresses growth of PC-3
human prostate cancer xenograft in vivo in association with Bax and
Bak induction. Clin Cancer Res. 12:6836–6843. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saunders LR and Verdin E: Sirtuins:
Critical regulators at the crossroads between cancer and aging.
Oncogene. 26:5489–5504. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Portmann S, Fahrner R, Lechleiter A, Keogh
A, Overney S, Laemmle A, Mikami K, Montani M, Tschan MP, Candinas D
and Stroka D: Antitumor effect of SIRT1 inhibition in human HCC
tumor models in vitro and in vivo. Mol Cancer Ther. 12:499–508.
2013. View Article : Google Scholar : PubMed/NCBI
|
